
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 100+ clinical research sites across the US and Europe, accelerating the path to market for novel therapies. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need.
About the Role
We are seeking a highly motivated Finance Analyst to join our growing team. In this role, you’ll partner closely with the Finance, Accounting and operational teams, as well as cross-functional stakeholders, to support strategic decision-making and optimize financial operations across the business. This is a high-impact role where you’ll gain hands-on experience supporting the financial operations of a rapidly scaling healthcare technology company. You will also play a key role in evolving our financial systems and infrastructure, particularly as we expand our joint venture (JV) partnerships and build for scale.
Responsibilities
What We’re Looking For
Required Qualifications
Preferred Qualifications
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact CandidateAccommodations@iterative.health.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.
Between 50 - 200 employees
2017
$191,600,000
Series B
$150,000,000 USD
Series A
$30,000,000 USD
Seed
$4,500,000 USD
Series A
$100,000 USD
Seed
$5,200,000 USD
Convertible Note
$1,800,000 USD